Learn more about Lindus Health from our blog page. Our posts cover an array of topics from clinical developments to diversity.
"The data pipeline, from medical record retrieval to structured EDC output, has to be designed for regulatory scrutiny from the start. Retrofitting data quality into an operational model that wasn't built for it creates avoidable risk at exactly the wrong stage of a program."
The digital transformation of the fertility space has brought us everything from period tracking apps to FDA-cleared digital contraceptives. Yet these tools are often grouped together under broad categories that obscure critical differences in their purpose and effectiveness.
Consumer health is a $6.3 trillion mainstream market with consumers prioritizing solutions that help them feel and look better and live longer. Yet in this crowded, fast-moving space, one principle stands above all others: trust is the foundation of strong consumer health brands.
Ovarian cancer remains one of the most lethal gynecological cancers, largely because diagnosis often comes too late. Around 70% of cases are detected at an advanced stage, with approximately 300,000 new cases each year.
Every cancer case in a large screening trial must be fully documented, with complete diagnostic, staging, treatment, and outcome data. Losing even a small number of cases to incomplete follow-up can undermine the statistical power the entire study was designed to achieve. The operational model has to be built around preventing that from the start.
"Clinical trials for diagnostics are increasingly time-consuming and expensive, given the large volumes of patients required. Identification and proper enrollment at accredited sites alongside novel methods of reaching patients remotely are promising developments for speeding and focusing efforts."
Explore how a groundbreaking clinical trial can shape the future of drug approval processes, influence regulatory decisions, and redefine treatment standards in the pharmaceutical industry..
Discover the ins and outs of GLP-1 receptor agonists in this comprehensive article.